StonvexLoading…
StonvexStonvexStonvexCore line items from UWMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.16B | $2.67B | $2.17B | $2.37B |
Operating Income | $250.90M | $335.96M | $-76.29M | $934.67M |
Net Income | $27.38M | $14.40M | $-13.23M | $41.72M |
EPS (Diluted) | $0.12 | $0.13 | $-0.14 | $0.45 |
Total Assets | $16.93B | $15.67B | $11.87B | $13.60B |
Total Liabilities | $15.34B | $13.62B | $9.40B | $10.43B |
Cash & Equivalents | $503.36M | $507.34M | $497.47M | $704.90M |
Free Cash Flow OCF − CapEx | $-2.72B | $-6.28B | $138.81M | $8.24B |
Shares Outstanding | 1.60B | 111.37M | 93.25M | 92.48M |